Development of Strategies to adapt to new Market Arrangements
There are existing similarities in process and requirements for drugs and devices. Although for medical devices, payers do not require certain level of evidence as for pharmaceuticals, requirements actually grow and get stringent as for pharmaceuticals.
Medical devices may have more challenges doing randomized clinical trials and generating high-quality economic evidence than pharmaceuticals; the pace of innovation is different too.
Because of the way medical devices are produced, the price for the obsolete technology is rapidly driven down to help to create head room to fund the new approved technology. Price differences of new and obsolete technologies increase the cost difference too what results in changing implied incremental cost-effectiveness ratio.
In general, quality of manufacturing, safety, effectiveness, and cost effectiveness should be the four pillars underpinning the evaluation of medical devices.
- Evaluation of new EU Regulations for Medical Devices
- Gain valuable knowledge about the regulatory process
- Develop strategies to adapt to new market arrangements
- Learn how to keep competitive with the innovations
- Explore the procedures to get the CE Mark
- Examine the pricing challenges and opportunities
- Hear about reimbursement impact for the company’s finances
- Examine clinical and economic evaluation of devices
- Understand the requirements for market authorization in the EU
- Pharmaceutical companies
- Medical Device Companies
- BioTech companies
- HTA bodies/payers
- Medical Device & Technology Consulting
Primary Job Titles
Chiefs, VPs, Head, Directors, Managers, Analysts, Researchers of:
- Market Access
- Regulatory Compliance
- Quality Management
- Performance Improvement
- Collaborative Strategies
- Change and Risk Management
- R&D IT
Secondary Job Titles
- Business Development Director/Manager
- Marketing Director/Manager
- Customer Service Director